Abstract
Life sciences are experiencing a historical shift towards a quantitative, data-rich regime. This transition has been associated with the advent of bio-informatics: mathematicians, physicists, computer scientists and statisticians are now commonplace in the field, working on the analysis of ever larger data-sets. An open question regarding what should drive scientific progress in this new era remains: will biological insight become increasingly irrelevant in a world of hypothesis-free, unbiased data analysis? This piece offers a different perspective, pin-pointing that biological thought is more-than-ever relevant in a data-rich setting. Some of the novel highthroughput information being acquired in the field of neuro-degenerative disorders is highlighted here. As but one example of how theory and experiment can interact in this new reality, our efforts in developing an idiopathic neuro-degenerative disease hematopoietic stemcell ageing theory are described.
Keywords: Bio-informatics, biological insight, high-throughput data, data analysis, neuro-degenerative disease.
Current Drug Metabolism
Title:Biological Insight, High-Throughput Datasets and the Nature of Neuro-Degenerative Disorders
Volume: 14 Issue: 7
Author(s): André X. C. N. Valente, Paulo J. Oliveira, Svetlana F. Khaiboullina, András Palotás and Albert A. Rizvanov
Affiliation:
Keywords: Bio-informatics, biological insight, high-throughput data, data analysis, neuro-degenerative disease.
Abstract: Life sciences are experiencing a historical shift towards a quantitative, data-rich regime. This transition has been associated with the advent of bio-informatics: mathematicians, physicists, computer scientists and statisticians are now commonplace in the field, working on the analysis of ever larger data-sets. An open question regarding what should drive scientific progress in this new era remains: will biological insight become increasingly irrelevant in a world of hypothesis-free, unbiased data analysis? This piece offers a different perspective, pin-pointing that biological thought is more-than-ever relevant in a data-rich setting. Some of the novel highthroughput information being acquired in the field of neuro-degenerative disorders is highlighted here. As but one example of how theory and experiment can interact in this new reality, our efforts in developing an idiopathic neuro-degenerative disease hematopoietic stemcell ageing theory are described.
Export Options
About this article
Cite this article as:
Valente X. C. N. André, Oliveira J. Paulo, Khaiboullina F. Svetlana, Palotás András and Rizvanov A. Albert, Biological Insight, High-Throughput Datasets and the Nature of Neuro-Degenerative Disorders, Current Drug Metabolism 2013; 14 (7) . https://dx.doi.org/10.2174/13892002113149990100
DOI https://dx.doi.org/10.2174/13892002113149990100 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Try to Remember: Interplay between Memory and Substance Use Disorder
Current Drug Targets Immunotherapy of Melanoma
Current Molecular Pharmacology Advances in High-Field Magnetic Resonance Spectroscopy in Alzheimer’s Disease
Current Alzheimer Research Fit to Practice: Augmenting Modular Cognitive Behavioral Procedures with Case Conceptualization
Current Psychiatry Reviews Turning Up the Pressure on Vascular Disease
Current Neurovascular Research The Role of Phospholipase D Enzyme(s) in Modulating Cell Signaling: Implications for Cancer Drug Development
Current Bioactive Compounds The Insulin-sensitizing Role of the Fat Derived Hormone Adiponectin
Current Pharmaceutical Design The Action of Prostaglandins on Ion Channels
Current Neuropharmacology Use of Toll-Like Receptor 3 Agonists Against Respiratory Viral Infections
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Anti Inflammatory and Anti Arthritic Activity of Different Milk Based Formulation of Curcumin in Rat Model
Current Drug Delivery Editorial [ Glycobiological Approach to Neurological Disorders Guest Editor: Keiko Kato ]
CNS & Neurological Disorders - Drug Targets Resolution-Associated Molecular Patterns (RAMPs) as Endogenous Regulators of Glia Functions in Neuroinflammatory Disease
CNS & Neurological Disorders - Drug Targets Hepatocellular Carcinoma Diagnostics, Treatments and Potential Theragnostics in the Asia-Pacific
Current Pharmacogenomics and Personalized Medicine Childhood Hypertension and Effects on Cognitive Functions: Mechanisms and Future Perspectives
CNS & Neurological Disorders - Drug Targets Insight Into the Emerging Role of Striatal Neurotransmitters in the Pathophysiology of Parkinson’s Disease and Huntington’s Disease: A Review
Current Neuropharmacology Melanocortin Receptors as Drug Targets for Disorders of Energy Balance
CNS & Neurological Disorders - Drug Targets Pharmacogenomics of COPD
Current Pharmacogenomics Meet Our Editorial Board Member
Combinatorial Chemistry & High Throughput Screening Editorial (Thematic Issue: Playing Well with Others! Initiating and Sustaining Successful Collaborations between Industry, Academia and Government)
Current Topics in Medicinal Chemistry Individual Differences and Vulnerability to Drug Addiction: A Focus on the Endocannabinoid System
CNS & Neurological Disorders - Drug Targets